中文
| Catalogue |
|
|
| Recommend Products |
Novavax, Inc.
United States, Manufacturer, Hits: 912, Updated:12/17/2020
Gaithersburg, MD 20878 USA |
Company Profile
-
Novavax is uniquely qualified to address the enduring need for innovative vaccines.
We are a late-stage biotechnology company that promotes improved global health through the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases.
We have more than a decade of experience contending with some of the world’s most devastating diseases, including COVID-19, seasonal influenza, RSV, Ebola, MERS, and SARS. Hard-won lessons and significant advances illustrate that our proven technology has tremendous potential to make a substantial contribution to public health worldwide.
Our vaccine candidates are genetically engineered using three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis.
We are also developing proprietary immune-stimulating saponin-based adjuvants at Novavax AB, our wholly owned Swedish subsidiary. Matrix-M? has been shown to enhance immune responses and has been well tolerated in multiple clinical trials.
Company News
- Novavax and Takeda Finalize License Agreement for Novavax’COVID-19 Vaccine Candidate in Japan 3/1/2021
- Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United S... 2/23/2021
- Novavax Collaborated with SK Bioscience for 40 Million Doses of COVID-19 Vaccine for South Korea 2/18/2021
- Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine ... 2/5/2021
- Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial 1/29/2021
- Novavax Finalizes Agreement with Commonwealth of Australia for 51 Million Doses of COVID-19 Vaccin... 1/8/2021
- Novavax Announces Initiation of PREVENT-19 Pivotal Phase 3 Efficacy Trial of COVID-19 Vaccine in t... 12/29/2020
- Novavax Announces Agreement with Government of New Zealand for 10.7 Million Doses of COVID-19 Vacc... 12/17/2020